Colgate-Palmolive Company
NYSE:CLHousehold & Personal Products
-$0.71 today
- Market cap
- $78.58B
- Beta
- 0.32
- P/E (TTM)
- 34.5
- EPS (TTM)
- $2.60
- Dividend yield
- 2.33%
Volume 6.07M
Average 5.62M
CL EBITDA Margin
EBITDA as a percentage of revenue.
Colgate-Palmolive CompanyNYSE: CL
EBITDA Margin · Q3 FY2026 · quarter ended Sep 2026
EBITDA Margin narrows to 23.1%
EBITDA Margin was 23.1% in Q3 FY2026, down 0.6 pp from a year earlier. On a trailing-twelve-month basis it was 18.1%, down 5.8 pp year over year. Over 3 fiscal years it widened by 5.1 pp.
Context
- EBITDA Margin widened in 2 of the last 3 fiscal years.
What to watch
Whether EBITDA Margin reaches the consensus estimate from 14 analysts of 25.5% for the fiscal year ending Dec 2026, up from 23.9% in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterSep 2026
- 23.1%+1.3 pp QoQ
- Last fiscal yearDec 2025
- 23.9%-0.3 pp YoY
- LTMSep 2026
- 18.1%-5.8 pp YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -0.6 pp | +18.5 pp | +19.2 pp |
| 1 year | -0.3 pp | +1.6 pp | +1.9 pp |
| 3 years | +5.1 pp | +3.3 pp | -1.9 pp |
| 5 years | +3.7 pp | — | |
| 10 years | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- 23.9%
- Year-over-year change
- -0.3pp
| Period | Period end | EBITDA Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 23.9% | -0.3pp |
| FY2024 | 2024-12-31 | 24.1% | +2.3pp |
| FY2023 | 2023-12-31 | 21.8% | +3.1pp |
| FY2022 | 2022-12-31 | 18.8% | -2.8pp |
| FY2021 | 2021-12-31 | 21.6% | — |
EBITDA Margin vs competitors
How CL compares with its peers on the latest reported figures
- CL's LTM Sep 2026 EBITDA Margin of 18.1% is the lowest of the 7 companies compared; the peer median is 20.8%.
- Its year-over-year change of -5.8 pp is the lowest of 7, against a peer median of -0.5 pp.
- Over three fiscal years its change of +5.1 pp compares with a peer median of +3.8 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Sep 2026 | 27.8% | -1.4 pp | +1.5 pp | |
| FY2025 | 22.8% | +1.4 pp | +5.2 pp | |
| LTM Sep 2026 | 21.0% | +1.4 pp | -2.5 pp | |
| LTM Sep 2026 | 20.6% | -1.5 pp | +5.5 pp | |
| LTM Sep 2026 | 19.9% | +0.4 pp | +9.7 pp | |
| LTM Jun 2026 | 19.2% | -1.5 pp | +2.4 pp | |
| LTM Sep 2026 | 18.1% | -5.8 pp | +5.1 pp | |
| Peer median (excluding CL) | 20.8% | -0.5 pp | +3.8 pp | |
Competitors are the stored peer set for CL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 17.42B | 17.97B | 19.46B | 20.1B | 20.38B |
| Cost of Revenue | 7.13B | 7.82B | 8.21B | 8B | 8.13B |
| Gross Profit | 10.29B | 10.15B | 11.25B | 12.11B | 12.25B |
| Gross Margin | 59.1% | 56.5% | 57.8% | 60.2% | 60.1% |
| Research & Development | 307M | 320M | 343M | 355M | 366M |
| Selling, General & Admin | 6.1B | 6.25B | 6.78B | 7.81B | 7.89B |
| Operating Expenses | 6.41B | 6.57B | 7.12B | 7.72B | 8.95B |
| Depreciation & Amortization | 556M | 545M | 567M | 605M | 630M |
| EBITDA | 3.76B | 3.37B | 4.25B | 4.85B | 4.87B |
| EBITDA Margin | 21.6% | 18.8% | 21.8% | 24.1% | 23.9% |
| Operating Income | 3.89B | 3.59B | 4.13B | 4.38B | 3.31B |
| Operating Margin | 22.3% | 20.0% | 21.2% | 21.8% | 16.2% |
| Interest Income | 17M | 14M | 55M | 67M | 75M |
| Interest Expense | 117M | 167M | 287M | 292M | 267M |
| Other Income / Expenses | (799M) | (925M) | (739M) | (427M) | (247M) |
| Income Before Tax | 3.09B | 2.66B | 3.39B | 3.96B | 3.06B |
| Pre-Tax Margin | 17.7% | 14.8% | 17.4% | 19.7% | 15.0% |
| Income Tax Expense | 749M | 693M | 937M | 907M | 798M |
| Net Income | 2.17B | 1.79B | 2.3B | 2.89B | 2.13B |
| Net Margin | 12.4% | 9.9% | 11.8% | 14.4% | 10.5% |
| EPS (Basic) | 2.56 | 2.13 | 2.78 | 3.53 | 2.64 |
| EPS (Diluted) | 2.55 | 2.13 | 2.77 | 3.51 | 2.63 |
| Weighted Avg Shares | 845M | 836.4M | 827.4M | 817.7M | 808.7M |
| Weighted Avg Shares (Diluted) | 848.3M | 838.8M | 829.2M | 822.5M | 811.1M |
Colgate-Palmolive Company
NYSE:CL
Intrinsic Alpha fair value
Locked
Current Price
$98.85
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.